Pakistan’s National Assembly passed the Virtual Assets Act 2026 on March 5, ending years of legal ambiguity for one of the world’s largest informal crypto marketsPakistan’s National Assembly passed the Virtual Assets Act 2026 on March 5, ending years of legal ambiguity for one of the world’s largest informal crypto markets

Pakistan Just Passed a Crypto Law Covering 40 Million Users and $20 Billion in Digital Assets

2026/03/07 09:45
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Pakistan’s National Assembly passed the Virtual Assets Act 2026 on March 5, ending years of legal ambiguity for one of the world’s largest informal crypto markets.

The legislation creates a dedicated regulatory authority, mandates licensing for all crypto service providers, and introduces a capital gains tax on digital asset conversions.

What the Law Creates

The Act establishes the Pakistan Virtual Assets Regulatory Authority, known as PVARA, as the sole independent regulator for the industry. PVARA is authorized to issue mandatory licenses for crypto exchanges, wallet providers, and custodians operating in Pakistan. It can block unlicensed platforms from operating and levy fines on entities without local registration.

All licensed platforms must provide retail investors with disclosures under a Risk Disclosure Framework built into the legislation. That consumer protection requirement mirrors similar mandates in the UAE, EU, and UK frameworks, standardizing what users must be told before they can access crypto services through regulated channels.

A 5% capital gains tax applies to crypto-to-fiat conversions, creating a direct revenue stream for the national treasury from an asset class that has operated entirely outside the tax base until now.

The Scale of What Is Being Regulated

The numbers cited during the bill’s reading put Pakistan’s crypto situation in perspective. Over 40 million users hold an estimated $18 billion to $20 billion in digital assets. That user base is larger than the entire population of many countries with active crypto regulatory frameworks. Most of that activity has been happening without legal clarity, through grey market channels, and outside any formal oversight structure.

The State Bank of Pakistan recommended regulation over prohibition in 2025 specifically to address capital flight and formalize the grey remittance market. Pakistan has a massive overseas diaspora sending money home through informal channels. Regulated crypto infrastructure offers a cheaper and faster alternative to traditional remittance networks, and the SBP recognized that banning crypto would push that activity further underground rather than eliminate it.

Solana Is Now the Biggest Stablecoin Network by Volume

The FATF Angle

Aligning with Financial Action Task Force standards on anti-money laundering and counter-terrorism financing is listed as a primary goal of the Act. Pakistan has spent years on FATF grey lists due to weaknesses in its financial oversight framework. A regulated crypto sector with mandatory AML and KYC requirements at licensed exchanges is part of a broader effort to demonstrate compliance with international financial standards.

The timing connects to a global pattern visible across this week’s regulatory news. Dubai acted against unlicensed KuCoin entities. Kazakhstan formalized a national crypto reserve framework. The U.S. submitted its SEC interpretive framework to the White House. Countries that have been watching from the sidelines are moving toward formal regulatory positions simultaneously, driven partly by FATF pressure and partly by recognition that informal crypto markets do not disappear when ignored.

The post Pakistan Just Passed a Crypto Law Covering 40 Million Users and $20 Billion in Digital Assets appeared first on ETHNews.

Market Opportunity
The AI Prophecy Logo
The AI Prophecy Price(ACT)
$0.01324
$0.01324$0.01324
+1.76%
USD
The AI Prophecy (ACT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09